Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Completes Ph 1a Clinical Study on OLX-07010
Home
>
News
>
Oligomerix Completes Ph 1a Clinical Study on OLX-07010
Print
Oligomerix
>
News
>
Oligomerix Completes Ph 1a Clinical Study on OLX-07010
Oligomerix Completes Ph 1a Clinical Study on OLX-07010
Post navigation
Previous Post
Oligomerix Awarded $0.5 M phase I NIH SBIR Fast-Track Grant to Conduct Safety Studies that will Support Clinical Studies of OLX-07010 for Alzheimer’s Patients
vera
View posts by vera
Scroll to top
close ×
